In a recent UAB MedCast episode, UAB Division of Endocrine Surgery Assistant Professor Jessica Fazendin, M.D., Associate Professor Brenessa Lindeman, M.D., MEHP, and UAB Division of Gastrointestinal Surgery Professor John Porterfield, M.D., provide updates on hyperthyroidism.
Porterfield begins the discussion by explaining the prevalence and diagnostic steps confirming hyperthyroidism, a condition characterized by the overproduction of thyroid hormones. He highlights the main symptoms of thyroid disease, such as weight loss and an elevated heart rate, and describes how basic thyroid function tests assist in diagnosis. While the diagnosis and causes of the disease have remained stable, he notes that treatments for different types of hyperthyroidism, such as Graves' disease, continue to evolve.
Fazendin expands on recent research exploring the outcomes of surgical interventions for hyperthyroidism, particularly for patients who don't respond to medication. Her study of over 200 patients indicates surgery can safely alleviate symptoms and cure the condition. The research challenges the traditional medical requirement for patients to reach normal thyroid function before surgery, suggesting that surgery can be conducted without the risks previously associated with hyperthyroid surgery under anesthesia.
Lindeman contributes by discussing studies that highlight the systemic effects of untreated hyperthyroidism, notably a Finnish study indicating elevated cardiovascular risks in untreated patients or those inadequately treated with radioactive iodine. This underscores the need for active treatment strategies.
Both Lindeman and Porterfield emphasize the role of telemedicine in improving patient access to surgery and care, facilitating timely and effective treatment. Porterfield notes the advances that have led to shorter hospital stays, making surgery a more viable option, while Fazendin stresses the importance of a multidisciplinary approach involving collaboration with endocrinologists and primary care physicians. Together, they highlight UAB's commitment to advancing research and treatment guidelines to optimize patient outcomes in hyperthyroidism.
“We're very happy here at UAB Medicine to be able to work with patients and customize those treatment plans to ensure the greatest rates of success for each and every individual that we see,” Lindeman said during the interview.
Listed to the UAB Medcast here.